ProPhase Labs logo
ProPhase Labs PRPH

Quarterly report 2025-Q3
added 11-19-2025

report update icon

ProPhase Labs Long Term Debt Current 2011-2026 | PRPH

Annual Long Term Debt Current ProPhase Labs

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
301 K 663 K 329 K - - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
663 K 301 K 431 K

Long Term Debt Current of other stocks in the Drug manufacturers industry

Issuer Long Term Debt Current Price % 24h Market Cap Country
Aerie Pharmaceuticals Aerie Pharmaceuticals
AERI
4.36 M - - $ 754 M usaUSA
Canopy Growth Corporation Canopy Growth Corporation
CGC
7.46 M $ 1.11 4.25 % $ 119 M canadaCanada
AcelRx Pharmaceuticals AcelRx Pharmaceuticals
ACRX
5.36 M - 7.5 % $ 6.35 M usaUSA
Catalent Catalent
CTLT
13 M - - $ 11.5 B usaUSA
Adamis Pharmaceuticals Corporation Adamis Pharmaceuticals Corporation
ADMP
343 K - 0.86 % $ 117 M usaUSA
DURECT Corporation DURECT Corporation
DRRX
1.38 M - - $ 50.1 M usaUSA
Endo International plc Endo International plc
ENDP
956 K - - $ 28.9 M irlandaIrlanda
Agile Therapeutics Agile Therapeutics
AGRX
366 K - 10.11 % $ 58.2 M usaUSA
Evoke Pharma Evoke Pharma
EVOK
13.4 K - - $ 36.6 M usaUSA
Evolus Evolus
EOLS
2.53 M $ 5.61 35.71 % $ 362 M usaUSA
Alimera Sciences Alimera Sciences
ALIM
634 K - - $ 142 M usaUSA
Avadel Pharmaceuticals plc Avadel Pharmaceuticals plc
AVDL
582 K - - $ 2.06 B franceFrance
Harrow Health Harrow Health
HROW
887 K $ 39.84 3.2 % $ 1.46 B usaUSA
Jupiter Wellness Jupiter Wellness
JUPW
213 K - - $ 33.6 M usaUSA
China Pharma Holdings China Pharma Holdings
CPHI
39.3 K $ 0.58 4.82 % $ 10.1 M chinaChina
Cumberland Pharmaceuticals Cumberland Pharmaceuticals
CPIX
357 K $ 3.93 -14.3 % $ 55.3 M usaUSA
Calliditas Therapeutics AB (publ) Calliditas Therapeutics AB (publ)
CALT
3.91 M - -0.1 % $ 2.03 B schwedenSchweden
HEXO Corp. HEXO Corp.
HEXO
914 K - 2.45 % $ 38.1 M canadaCanada
Neoleukin Therapeutics Neoleukin Therapeutics
NLTX
2.56 M - - $ 193 M canadaCanada
Aurora Cannabis Aurora Cannabis
ACB
5.38 M $ 3.67 5.46 % $ 86.3 M canadaCanada
Athenex Athenex
ATNX
2.09 M - -23.39 % $ 1.76 M usaUSA
Organogenesis Holdings Organogenesis Holdings
ORGO
4.27 M $ 2.96 2.96 % $ 390 M usaUSA
Emergent BioSolutions Emergent BioSolutions
EBS
3.5 M $ 8.93 0.17 % $ 457 M usaUSA
Assertio Holdings Assertio Holdings
ASRT
928 K $ 12.19 2.44 % $ 866 M usaUSA
Radius Health Radius Health
RDUS
613 K - - $ 1.42 B usaUSA
Bausch Health Companies Bausch Health Companies
BHC
61 M $ 5.65 -1.4 % $ 2.06 B canadaCanada
Lannett Company Lannett Company
LCI
2.06 M - 1.15 % $ 7.11 M usaUSA
Eagle Pharmaceuticals Eagle Pharmaceuticals
EGRX
1.53 M - -39.89 % $ 27.7 M usaUSA
OrganiGram Holdings OrganiGram Holdings
OGI
1.03 M $ 1.41 3.2 % $ 402 M canadaCanada
Perrigo Company plc Perrigo Company plc
PRGO
25.7 M $ 11.63 2.15 % $ 1.61 B usaUSA
Rockwell Medical Rockwell Medical
RMTI
1.38 M $ 0.9 0.44 % $ 21 M usaUSA
Sundial Growers Sundial Growers
SNDL
34.3 M $ 1.56 1.63 % $ 3.37 M canadaCanada
TherapeuticsMD TherapeuticsMD
TXMD
1.47 M $ 2.25 1.35 % $ 23.5 M usaUSA
Pacira BioSciences Pacira BioSciences
PCRX
8.89 M $ 22.89 3.57 % $ 1.06 B usaUSA
Veru Veru
VERU
1.07 M $ 2.6 3.17 % $ 351 M usaUSA
PetIQ PetIQ
PETQ
7.61 M - 1.64 % $ 400 M usaUSA
OptiNose OptiNose
OPTN
911 K - - $ 1.08 B usaUSA
Viatris Viatris
VTRS
80.6 M $ 14.81 -0.57 % $ 17.8 B usaUSA
PLx Pharma PLx Pharma
PLXP
622 K - -27.8 % $ 2.56 M usaUSA
Recro Pharma Recro Pharma
REPH
1.1 M - -4.76 % $ 65.3 M usaUSA
cbdMD cbdMD
YCBD
98.7 K $ 0.74 -3.77 % $ 3.19 M usaUSA
SCYNEXIS SCYNEXIS
SCYX
340 K $ 0.76 0.96 % $ 36.4 M usaUSA
Solid Biosciences Solid Biosciences
SLDB
1.79 M $ 6.26 5.03 % $ 256 M usaUSA
Sonoma Pharmaceuticals Sonoma Pharmaceuticals
SNOA
58 K $ 2.74 -0.36 % $ 3.4 M usaUSA
Tricida Tricida
TCDA
2.74 M - - $ 3.25 M usaUSA
Tilray Tilray
TLRY
2.47 M $ 7.45 1.22 % $ 4.6 B canadaCanada
Zynerba Pharmaceuticals Zynerba Pharmaceuticals
ZYNE
215 K - - $ 55.5 M usaUSA